|
Volumn 79, Issue 1-5, 2001, Pages 103-107
|
Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy
|
Author keywords
Aromatase inhibitors; Ki67; Neoadjuvant therapy; PgR
|
Indexed keywords
ANASTROZOLE;
ESTROGEN RECEPTOR;
LETROZOLE;
PROGESTERONE RECEPTOR;
PROTEIN;
TAMOXIFEN;
BREAST CARCINOMA;
CANCER ADJUVANT THERAPY;
CANCER SURGERY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MECHANISM;
DRUG POTENCY;
DRUG RESPONSE;
FEMALE;
FIBROSIS;
HORMONE DEPENDENCE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MAJOR CLINICAL STUDY;
MAMMOGRAPHY;
MASTECTOMY;
PATHOLOGY;
POSTMENOPAUSE;
STAINING;
TREATMENT OUTCOME;
TUMOR BIOPSY;
TUMOR VOLUME;
ULTRASOUND;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
ENZYME INHIBITORS;
ESTROGEN RECEPTOR MODULATORS;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
KI-67 ANTIGEN;
MENOPAUSE;
NEOPLASMS, HORMONE-DEPENDENT;
NITRILES;
RECEPTORS, ESTROGEN;
RECEPTORS, PROGESTERONE;
TAMOXIFEN;
TRIAZOLES;
|
EID: 0035717497
PISSN: 09600760
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-0760(01)00149-2 Document Type: Conference Paper |
Times cited : (51)
|
References (10)
|